Vesicle-forming properties of new phospholipid analogues derived from N-phosphonoacetyl-L-aspartate (PALA):: Particle features and morphology in relation with alkyl chain lengths

被引:16
作者
Oliger, P
Schmutz, M
Hebrant, M
Grison, C
Coutrot, P
Tondre, C
机构
[1] Univ Nancy 1, Lab Chim Phys Organ & Colloidale, Inst Nanceien Chim Mol, UMR CNRS 7565, F-54506 Vandoeuvre Nancy, France
[2] Univ Nancy 1, Lab Chim Organ 2, Inst Nanceien Chim Mol, UMR CNRS 7565, F-54506 Vandoeuvre Nancy, France
[3] ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch, France
关键词
D O I
10.1021/la0100845
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Phospholipid analogues of the anticancer agent PALA (N-phosphonoacetyl-L-aspartate) with varying alkyl chain lengths were synthesized: diC(12)-, diC(14)-, diC(16)-, and diC(18)-PALA. Their aptitude to form vesicles was tested using two different preparation techniques: sonication and extrusion. The particles obtained were characterized from cryogenic temperature transmission electron microscopy imaging, showing a continuous morphological evolution when increasing the alkyl chain lengths. Spherical vesicles were obtained for the smaller chain lengths, which evolve toward disklike vesicles, faceted objects, and flat disk structures for longer chain lengths. This evolution was correlated with the transition temperatures, T-m, from the gel state to the liquid crystalline state, which were independently determined. The sonication method was found to lead to smaller objects and increased particle fragmentation compared to extrusion. Particle size measurements and glucose entrapment experiments provided additional results in good agreement with the previous observations.
引用
收藏
页码:3893 / 3897
页数:5
相关论文
共 9 条
[1]   EFFECT OF BILAYER PHASE-TRANSITIONS ON VESICLE STRUCTURE AND ITS INFLUENCE ON THE KINETICS OF VIOLOGEN REDUCTION [J].
ANDERSSON, M ;
HAMMARSTROM, L ;
EDWARDS, K .
JOURNAL OF PHYSICAL CHEMISTRY, 1995, 99 (39) :14531-14538
[2]   Chiral lipophilic ligands .3. Control of enantioselectivity in copper(II)-catalyzed cleavage of alpha-amino acid esters by aggregate morphology [J].
Cleij, MC ;
Scrimin, P ;
Tecilla, P ;
Tonellato, U .
LANGMUIR, 1996, 12 (12) :2956-2960
[3]  
COLLINS KD, 1971, J BIOL CHEM, V246, P6599
[4]   New design of vesicle-forming potential anti-cancer agent [J].
Coutrot, P ;
Oliger, P ;
Grison, C ;
Joliez, S ;
Hébrant, M ;
Tondre, C .
NEW JOURNAL OF CHEMISTRY, 1999, 23 (10) :981-987
[5]   Improved in vitro growth inhibitory effect of N-(phosphonacetyl)-L-aspartic acid in immunoliposomes [J].
Kim, JS ;
Heath, TD .
JOURNAL OF CONTROLLED RELEASE, 1996, 40 (1-2) :101-109
[6]  
NATALE RB, 1982, CANCER TREAT REP, V66, P2091
[7]   MODULATION OF HUMAN OVARIAN TUMOR-CELL SENSITIVITY TO N-(PHOSPHONACETYL)-L-ASPARTATE (PALA) BY LIPOSOME DRUG CARRIERS [J].
SHARMA, A ;
STRAUBINGER, NL ;
STRAUBINGER, RM .
PHARMACEUTICAL RESEARCH, 1993, 10 (10) :1434-1441
[8]  
SWYRYD EA, 1974, J BIOL CHEM, V249, P6945
[9]   COMPARATIVE PROPERTIES AND METHODS OF PREPARATION OF LIPID VESICLES (LIPOSOMES) [J].
SZOKA, F ;
PAPAHADJOPOULOS, D .
ANNUAL REVIEW OF BIOPHYSICS AND BIOENGINEERING, 1980, 9 :467-508